Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) VP Jerome Cambre sold 4,880 shares of Viemed Healthcare stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total value of $35,721.60. Following the sale, the vice president owned 84,191 shares of the company's stock, valued at approximately $616,278.12. This represents a 5.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Viemed Healthcare Stock Performance
NASDAQ:VMD traded up $0.06 during midday trading on Tuesday, reaching $6.98. The stock had a trading volume of 17,288 shares, compared to its average volume of 174,126. Viemed Healthcare, Inc. has a 1-year low of $5.93 and a 1-year high of $9.81. The firm's fifty day simple moving average is $6.72 and its 200-day simple moving average is $7.02. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.48 and a quick ratio of 1.37. The stock has a market capitalization of $270.56 million, a P/E ratio of 20.49 and a beta of 1.33.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.08. Viemed Healthcare had a net margin of 5.80% and a return on equity of 10.38%. The business had revenue of $63.06 million for the quarter, compared to analyst estimates of $63.50 million.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. Divisadero Street Capital Management LP increased its position in shares of Viemed Healthcare by 84.8% during the fourth quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock valued at $5,183,000 after purchasing an additional 296,481 shares during the period. Wasatch Advisors LP increased its position in shares of Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company's stock valued at $10,683,000 after purchasing an additional 240,346 shares during the period. Forager Capital Management LLC increased its position in shares of Viemed Healthcare by 12.1% during the second quarter. Forager Capital Management LLC now owns 2,136,472 shares of the company's stock valued at $14,763,000 after purchasing an additional 230,670 shares during the period. Expect Equity LLC bought a new stake in shares of Viemed Healthcare during the fourth quarter valued at approximately $1,369,000. Finally, JPMorgan Chase & Co. increased its position in shares of Viemed Healthcare by 131.4% during the fourth quarter. JPMorgan Chase & Co. now owns 228,652 shares of the company's stock valued at $1,834,000 after purchasing an additional 129,854 shares during the period. 74.24% of the stock is owned by institutional investors.
Viemed Healthcare Company Profile
(
Get Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Recommended Stories
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.